GeneOne Life Science, Inc. (KRX:011000)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,730.00
-285.00 (-9.45%)
Last updated: Jun 5, 2025

GeneOne Life Science Revenue

GeneOne Life Science had revenue of 8.50B KRW in the quarter ending March 31, 2025, with 20.93% growth. This brings the company's revenue in the last twelve months to 37.19B, down -6.65% year-over-year. In the year 2024, GeneOne Life Science had annual revenue of 35.72B, down -11.15%.

Revenue (ttm)
37.19B
Revenue Growth
-6.65%
P/S Ratio
6.22
Revenue / Employee
885.53M
Employees
42
Market Cap
231.25B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202435.72B-4.48B-11.15%
Dec 31, 202340.20B-8.52B-17.48%
Dec 31, 202248.72B10.02B25.89%
Dec 31, 202138.70B-2.80B-6.75%
Dec 31, 202041.50B261.48M0.63%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,898.69B
Celltrion 3,662.23B
ALTEOGEN 151.65B
Yuhan 2,114.76B
SK Biopharmaceuticals 578.00B
HLB Co., Ltd. 74.64B
PharmaResearch 392.31B
LigaChem Biosciences 146.42B
Revenue Rankings